<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00935233</url>
  </required_header>
  <id_info>
    <org_study_id>CRUK-ICICLE</org_study_id>
    <secondary_id>CDR0000629681</secondary_id>
    <secondary_id>EU-20895</secondary_id>
    <nct_id>NCT00935233</nct_id>
  </id_info>
  <brief_title>Study of Biomarkers in Blood and/or Tumor Tissue Samples From Patients With Ductal Carcinoma in Situ and From Healthy Volunteers</brief_title>
  <official_title>ICICLE- A Study to Investigate the genetiCs of In Situ Carcinoma of the ductaL subtypE</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Queen Mary University of London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Institute (NCI)</source>
  <brief_summary>
    <textblock>
      RATIONALE: Studying genes in samples of blood and/or tumor tissue from patients with cancer
      may help doctors identify biomarkers related to cancer.

      PURPOSE: This research study is looking at blood and/or tumor tissue samples from patients
      with ductal carcinoma in situ and blood samples from healthy volunteers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:

      Primary

        -  To collect blood and/or tumor tissue of patients with ductal breast carcinoma in situ
           (DCIS) and their age- and ethnicity-matched controls to identify the inherited variation
           that predisposes women to develop DCIS.

        -  To determine the frequency of these variants.

        -  To determine the effect of these variants on tumor risk.

        -  To determine the benefit of testing for these variants in the clinical setting so that
           those at higher risk could be identified, counseled, and screened.

      Secondary

        -  To analyze the acquired genetic changes within DCIS to identify which cases are more
           likely to develop invasive disease.

      OUTLINE: This is a multicenter study.

      All participants complete a questionnaire to collect their family history, a brief medical
      history, and epidemiological data.

      Patients undergo collection of blood and/or tumor tissue samples; DNA is extracted for
      genotyping, comparison of allele and genotype frequencies (polymorphisms), genetic profiling,
      DNA analysis, and protein analysis. Histopathology reports are also collected. Healthy
      volunteers undergo collection of blood samples.

      PROJECTED ACCRUAL: A minimum of 3,000 patients and 3,000 controls will be accrued for this
      study.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2008</start_date>
  <primary_completion_date type="Anticipated">July 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <primary_outcome>
    <measure>Collection of blood and/or tumor tissue</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Frequency of genetic variants that predispose women to develop ductal carcinoma in situ (DCIS)</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of these variants on tumor risk</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Benefit of testing for these variants</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Analysis of acquired genetic changes within DCIS</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">6000</enrollment>
  <condition>Breast Cancer</condition>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>DNA analysis</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>polymorphism analysis</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>protein analysis</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>laboratory biomarker analysis</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>questionnaire administration</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>survey administration</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:

          -  Prior or current diagnosis of pure ductal carcinoma in situ (DCIS)

               -  Age â‰¤ 60 years at the time of diagnosis

               -  DCIS with contralateral synchronous or asynchronous invasive breast cancer is
                  permitted

               -  DCIS associated with microinvasion (foci &lt; 1 mm) is permitted

          -  Healthy age- and ethnicity-matched controls

               -  No history of DCIS

               -  No relative (up to second degree) diagnosed with DCIS

        PATIENT CHARACTERISTICS:

          -  Not specified

        PRIOR CONCURRENT THERAPY:

          -  Not specified
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rebecca Roylance, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Barts and the London School of Medicine and Dentistry</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Elinor Sawyer, MD</last_name>
    <affiliation>Cancer Research UK</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>North Devon District Hospital</name>
      <address>
        <city>Barnstaple</city>
        <state>England</state>
        <zip>EX31 4JB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Contact Person</last_name>
      <phone>44-1271-322-577</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Basildon University Hospital</name>
      <address>
        <city>Basildon</city>
        <state>England</state>
        <zip>SS16 5NL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Contact Person</last_name>
      <phone>44-1702-435-555</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cumberland Infirmary</name>
      <address>
        <city>Cambridge</city>
        <state>England</state>
        <zip>CB2 2QQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Williams, MD</last_name>
      <phone>44-122-321-7020</phone>
      <email>michael.williams@addenbrookes.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Colchester General Hospital</name>
      <address>
        <city>Colchester</city>
        <state>England</state>
        <zip>CO4 5HG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Contact Person</last_name>
      <phone>44-1206-744-893</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dartford &amp; Gravesham NHS Trust, Joyce Green Hospital</name>
      <address>
        <city>Dartford Kent</city>
        <state>England</state>
        <zip>DA1 5PL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Contact Person</last_name>
      <phone>44-1322-227-242</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dorset County Hospital</name>
      <address>
        <city>Dorchester</city>
        <state>England</state>
        <zip>DT1 2JY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Contact Person</last_name>
      <phone>44-1305-251-150</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwick Park Hospital</name>
      <address>
        <city>Harrow</city>
        <state>England</state>
        <zip>HA1 3UJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Contact Person</last_name>
      <phone>44-20-8864-3232</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>West Middlesex University Hospital</name>
      <address>
        <city>Isleworth</city>
        <state>England</state>
        <zip>TW7 6AF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Contact Person</last_name>
      <phone>44-20-8321-6781</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Barts and the London School of Medicine</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>EC1M 6BQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Roylance, MD</last_name>
      <phone>44-20-7014-0460</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Helen Rollason Cancer Care Centre at North Middlesex Hospital</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>N18 1QX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Contact Person</last_name>
      <phone>44-20-7830-2184</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Research UK Clinical Groups at Guy's King's &amp; St. Thomas' Hospitals</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>SE1 9RT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elinor Sawyer, MD</last_name>
      <phone>44-171-737-3642</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>King's College Hospital</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>SE5 9RS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Contact Person</last_name>
      <phone>44-20-3299-9000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Charing Cross Hospital</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>SW10 9NH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charles P. Lowdell, MD, BSc, MBBS, FRCP, FRCR</last_name>
      <phone>44-20-8846-1742</phone>
      <email>charles.lowdell@imperial.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mount Vernon Cancer Centre at Mount Vernon Hospital</name>
      <address>
        <city>Northwood</city>
        <state>England</state>
        <zip>HA6 2RN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Contact Person</last_name>
      <phone>44-1923-844-805</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Princess Royal University Hospital</name>
      <address>
        <city>Orpington, Kent</city>
        <state>England</state>
        <zip>BR6 8ND</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elinor Sawyer, MD</last_name>
      <phone>44-20-7188-3751</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Southend University Hospital NHS Foundation Trust</name>
      <address>
        <city>Westcliff-On-Sea</city>
        <state>England</state>
        <zip>SS0 0RY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Robinson, MD</last_name>
      <phone>44-1702-221-226</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dumfries &amp; Galloway Royal Infirmary</name>
      <address>
        <city>Dumfries</city>
        <state>Scotland</state>
        <zip>DG1 4AP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Contact Person</last_name>
      <phone>44-1387-246-246</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bronglais District General Hospital</name>
      <address>
        <city>Aberystwyth</city>
        <state>Wales</state>
        <zip>SY23 1ER</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Contact Person</last_name>
      <phone>44-1970-635-390</phone>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>July 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 7, 2009</study_first_submitted>
  <study_first_submitted_qc>July 7, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 8, 2009</study_first_posted>
  <last_update_submitted>August 9, 2013</last_update_submitted>
  <last_update_submitted_qc>August 9, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 12, 2013</last_update_posted>
  <keyword>ductal breast carcinoma in situ</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma in Situ</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

